99.67% HPLCRetatrutide
from$69.99
Tirzepatide
Incretin & amylin analogs · lyophilized powder
$89.99per vial
Strength
Buy more, save more applies per product
2 vialssave 5%
3 vialssave 8%
4+ vialssave 10%
1
Earn 890 reward points with this order
In stockFree tracked delivery
Lab report · current batch
All reportsTirzepatide · 10 mgBatch GLP-260810-N5 · Tested Jul 27, 2026
99.53%HPLC purity
- Identity (LC-MS)Confirmed
- SterilityNo growth
- Endotoxin (LAL)0.17 EU/mL
- Heavy metals (ICP-MS)< 0.1 ppm
Research overview
Tirzepatide (LY3298176) is a 39-amino-acid peptide that activates both the GIP and GLP-1 receptors, acylated with a C20 fatty-diacid moiety that binds albumin for once-weekly study designs. Its sequence is based on GIP, with changes that add GLP-1 receptor activity.
Developed at Eli Lilly, tirzepatide is the reference dual incretin agonist in receptor-pharmacology research. Preclinical studies found larger effects on body weight and food intake in mice than with a GLP-1 receptor agonist alone, and two published head-to-head clinical trials compared it with semaglutide. Use matched medium conditions when comparing potencies in vitro. See tirzepatide vs semaglutide.
Further reading: Tirzepatide vs semaglutide: molecules, mechanisms and head-to-head trials · Retatrutide research: the GIP, GLP-1 and glucagon triple agonist
Product details
Tirzepatide is a 39-amino-acid dual agonist of the GIP and GLP-1 receptors, acylated with a C20 fatty-diacid moiety. Supplied as a lyophilized reference material for receptor-pharmacology research.
| Form | Lyophilized powder, sealed vial |
|---|
Storage & handling
Keep unopened vials sealed, dry and protected from light at −20 °C for long-term storage. Short-term storage at 2-8 °C is acceptable. Handle according to your laboratory's procedures.
Shipping
Every order ships free with tracked delivery. You'll see the delivery options and estimated times at checkout, and get a tracking number and a tracking page when your order ships. Availability depends on your shipping destination.
Questions
What makes tirzepatide a dual agonist?
One peptide activates both the GIP receptor and the GLP-1 receptor.
How does tirzepatide differ from retatrutide?
Retatrutide also activates the glucagon receptor, making it a triple agonist.
What's in the vial?
Tirzepatide at the strength you choose. No diluent or accessories are included.
Can I check the lab report for my vial?
Yes. The batch number on your vial matches a report on this page or in our lab report library, with a link to verify it on the lab's website where available.
Is this product for human use?
No. It's sold for laboratory research use only and isn't for human or veterinary use.
Previous batches
- No earlier batches published for this strength.
10 mg$89.99
1
